Ligand and Structure Based Virtual Screening Strategies for Hit-Finding and Optimization of Hepatitis C Virus (HCV) Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|17|2612-2619

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.17, 2011-06, pp. : 2612-2619

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Identification of New CD38 Inhibitors by Combined Structure and Ligand Based Virtual Screening Approaches of ZINC Database

By  

Letters in Drug Design & Discovery, Vol. 15, Iss. 6, 2018-04 ,pp. : 654-660

Bentham Science Publishers

Access to resources Recommend Favorite

Fragment-Based Development of HCV Protease Inhibitors for the Treatment of Hepatitis C

By  

Current Computer - Aided Drug Design, Vol. 8, Iss. 1, 2012-03 ,pp. : 55-61

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand Docking and Structure-based Virtual Screening in Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-05 ,pp. : 1006-1014

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand-Based Approaches in Virtual Screening

By  

Current Computer - Aided Drug Design, Vol. 4, Iss. 3, 2008-09 ,pp. : 180-190

Bentham Science Publishers

Access to resources Recommend Favorite

The Second-generation of Highly Potent Hepatitis C Virus (HCV) NS3/4A Protease Inhibitors: Evolutionary Design Based on Tailor-made Amino Acids, Synthesis and Major Features of Bio-activity

By  

Current Pharmaceutical Design, Vol. 23, Iss. 30, 2017-11 ,pp. : 4493-4554

Bentham Science Publishers

Access to resources Recommend Favorite